Perotto and colleagues took advantage of the thiol groups on the cysteine amino acids in keratin. They thought they could ...

Polyethylene glycol (PEG) 3350; pwd for reconstitution. Polyethylene glycol 3350 cleanses the bowel by induction of diarrhea. The osmotic activity of polyethylene glycol 3350, in combination with ...

Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for ...

Glenmark Therapeutics launches polyethylene glycol 3350, powder for solution, 17 grams/capful in US: Our Bureau, Mumbai Monday, March 10, 2025, 14:15 Hrs [IST] Glenmark Therapeuti ...

Real-world data support clinical trial results showing less gastrointestinal toxicity with use of a rectal spacer during prostate cancer radiation therapy.

Glenmark Pharmaceuticals launches polyethylene glycol 3350, a constipation treatment medicine in the US. The OTC product aims ...

According to Nielsen syndicated data for the latest 52 weeks' period ending 22 February 2025, the MiraLAX Powder for Solution, 17 grams (OTC) market achieved annual sales of approximately $555.7 ...

Glenmark Pharmaceuticals has introduced a new constipation treatment, polyethylene glycol 3350 powder, to the US market. This launch aims to fulfill the rising demand for a fresh supplier in the ...

Glenmark Therapeutics Inc., USA announced today the launch of its Polyethylene Glycol 3350, Powder for Solution, an ...

Glenmark Pharmaceuticals has announced the launch of 'Polyethylene Glycol 3350 Powder for Solution' as on OTC product in the US market.

USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX®2 Powder for Solution ...